Moneycontrol PRO
you are here: HomeNewsDrug
Jump to
314 Results Found
  • Glenmark launches generic COPD treatment drug in Spain Oct 11, 2021 12:57 PM IST

    Glenmark launches generic COPD treatment drug in Spain

    Studies show that close to 2.5 million people suffer from COPD in Spain.

  • Drug makers Glenmark, Aurobindo recall products in US Oct 03, 2021 12:18 PM IST

    Drug makers Glenmark, Aurobindo recall products in US

    As per the latest enforcement report issued by the US Food and Drug Administration (USFDA), Glenmark's US-based unit is recalling various products in the US market.

  • Alembic Pharma gets USFDA nod for cancer treatment drug Jul 09, 2021 12:23 PM IST

    Alembic Pharma gets USFDA nod for cancer treatment drug

    The approved product is therapeutically equivalent to the reference listed drug product Tarceva tablets of OSI Pharmaceuticals, LLC.

  • Explained: What does FDA approval of Biogen's Alzheimer's drug mean for patients? Jun 08, 2021 09:46 AM IST

    Explained: What does FDA approval of Biogen's Alzheimer's drug mean for patients?

    The FDA approved Aduhelm for the treatment of Alzheimer's disease. The decision did not define the patient population for whom the treatment is appropriate.

  • Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US Jun 06, 2021 01:41 PM IST

    Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US

    Atorvastatin is indicated to lower cholesterol in the blood for adults and children over ten years of age.

  • Merck says study shows COVID-19 drug causes quick reduction in virus Mar 06, 2021 01:25 PM IST

    Merck says study shows COVID-19 drug causes quick reduction in virus

    "The secondary objective findings in this study, of a quicker decrease in infectious virus among individuals with early COVID-19 treated with molnupiravir, are promising," said William Fischer, Associate Professor of Medicine at the University of North Carolina School of Medicine, in a statement from the companies.

  • Glenmark gets USFDA nod to market generic drug for muscle pain May 27, 2020 10:59 AM IST

    Glenmark gets USFDA nod to market generic drug for muscle pain

    Glenmark Pharmaceuticals Inc, USA has been granted final approval by the US Food and Drug Administration (USFDA) for Chlorzoxazone tablets USP, in strength of 375 mg and 750 mg, the drug maker said in a statement.

  • Lupin launches generic drug in US market May 19, 2020 01:15 PM IST

    Lupin launches generic drug in US market

    The company has launched of authorised generic version of Bausch Health's Apriso (Mesalamine extended-release capsules 0.375 g) in the US, Lupin said in a statement.

  • Dr Reddy's launches generic lipid-regulating tablets in US Apr 27, 2020 01:44 PM IST

    Dr Reddy's launches generic lipid-regulating tablets in US

    The company's tablets are available in 54 mg dose in bottle count size of 90, and 160 mg dose in bottle count sizes of 90 and 500

  • Alembic gets USFDA nod for generic ophthalmic solution Apr 20, 2020 12:56 PM IST

    Alembic gets USFDA nod for generic ophthalmic solution

    Alembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market Alcaftadine ophthalmic solution, in the American market.

  • Coronavirus pandemic | Dr Reddy’s working on generic version of remdesivir: Report Apr 16, 2020 11:12 AM IST

    Coronavirus pandemic | Dr Reddy’s working on generic version of remdesivir: Report

    Remdesivir, which is yet to get regulatory approval, has improved the condition of 36 critically ill COVID-19 patients in a multi-country compassionate use programme.

  • India has enough HCQ capacity to serve demand, clinical trial outcome is crucial Apr 10, 2020 07:41 PM IST

    India has enough HCQ capacity to serve demand, clinical trial outcome is crucial

    Despite limited clinical evidence, HCQ is now used by many countries for treating COVID-19 patients.

  • Coronavirus pandemic | Promising new treatment fails Mar 20, 2020 10:51 AM IST

    Coronavirus pandemic | Promising new treatment fails

    The study tested Kaletra, a combination of two antiviral medicines, lopinavir and ritonavir, that are normally used to treat HIV

  • Kerala CM launches ''Yodhavu'' mobile appl to combat drug menace Feb 15, 2020 06:40 PM IST

    Kerala CM launches ''Yodhavu'' mobile appl to combat drug menace

    Drug abuse among youngsters was painful, Vijayan said and wanted people to extend support to the police and excise departments in curbing the menace.

  • GFP leader submits 'secret' report to PM on Goa drugs nexus Dec 07, 2019 03:30 PM IST

    GFP leader submits 'secret' report to PM on Goa drugs nexus

    Talking to reporters, GFP MLA Vinod Paliencar said he submitted the report to Modi last week.

  • USFDA approves AstraZeneca diabetes drug for treating heart failure risk Oct 21, 2019 12:42 PM IST

    USFDA approves AstraZeneca diabetes drug for treating heart failure risk

    The approval by the U.S. Food and Drug Administration is based on results from the DECLARE-TIMI 58 clinical trial, the London-listed company said, and follows a similar approval by the European authorities in August.

  • Clinical trial data on Suven's SUVN-502 Alzheimer's drug delayed till September: Sources Jul 17, 2019 07:57 PM IST

    Clinical trial data on Suven's SUVN-502 Alzheimer's drug delayed till September: Sources

    Suven had planned to release the study's top-line data at the Alzheimer's Association International Conference (AAIC) in Los Angeles on July 17, but this has now been delayed due to technical reasons

  • Alembic Pharma gets USFDA nod for overactive bladder treatment drug May 21, 2019 11:15 AM IST

    Alembic Pharma gets USFDA nod for overactive bladder treatment drug

    The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Solifenacin Succinate tablets in the strengths of 5 mg and 10 mg, Alembic Pharmaceuticals said in a BSE filing.

  • Zydus Cadila gets USFDA nod to market Potassium Chloride capsules Mar 13, 2019 12:33 PM IST

    Zydus Cadila gets USFDA nod to market Potassium Chloride capsules

    The company has received approval from the US Food and Drug Administration (USFDA) to market the drug in the strengths of 8 mEq (600 mg) and 10 mEq (750 mg), Zydus Cadila said in a BSE filing.

  • Strides gets USFDA nod to market laxative drug in US Dec 24, 2018 11:22 AM IST

    Strides gets USFDA nod to market laxative drug in US

    Strides Pharma Global, Singapore, has received approval for Polyethylene Glycol 3350 and Electrolytes for Oral Solution USP in the strengths of 236 grams/2.97 grams/6.74 grams/5.86 grams/22.74 grams/4 Liter from the United States Food and Drug Administration (USFDA), Strides Pharma Science said in a filing to BSE.

  • Alembic Pharma's subsidiary gets USFDA nod peptic ulcer drug Dec 04, 2018 11:07 AM IST

    Alembic Pharma's subsidiary gets USFDA nod peptic ulcer drug

    The company's wholly owned subsidiary Orit Laboratories LLC has received approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Glycopyrrolate tablets USP in the strengths of 1 mg and 2mg, Alembic Pharmaceuticals said in a BSE filing.

  • Dr Reddy's launches blood pressure drug in US Nov 28, 2018 11:19 AM IST

    Dr Reddy's launches blood pressure drug in US

    Dr Reddy's Laboratories Ltd launched Chlorthalidone tablets USP in the strengths of 25 mg and 50 mg, a therapeutic equivalent generic version of Hygroton tablets, Dr Reddy's Laboratories said in a BSE filing.

  • Zydus Cadila launches generic erectile dysfunction drug in US Nov 01, 2018 02:20 PM IST

    Zydus Cadila launches generic erectile dysfunction drug in US

    The company has launched the tablets in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg in the US market after receiving the final approval from the United States Food and Drug Adminstration (USFDA), Zydus Cadila said in a statement.

  • FDC receives EIR from US health regulator for Waluj plant Oct 31, 2018 01:52 PM IST

    FDC receives EIR from US health regulator for Waluj plant

    The company said it had submitted a detailed compliance report to the US Food and Drug Administration (USFDA) within the stipulated period in response to the Form 483 containing eight observations issued to it by the regulator.

  • Zydus Cadila gets USFDA nod for breast cancer drug Oct 05, 2018 12:50 PM IST

    Zydus Cadila gets USFDA nod for breast cancer drug

    The company has received approval from the US Food and Drug Administration (USFDA) to market the drug in the strength of 25 mg, Zydus Cadila said in a BSE filing.

Sections
ISO 27001 - BSI Assurance Mark